Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: Insulin resistance, friend or foe?

Nutrition and Metabolism

Volumn 6, Issue , 2009, Pages

  Nunn, Alistair V W ^a   Bell, Jimmy D ^a   Guy, Geoffrey W ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Porton Down Science Park   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALCOHOL; ENDOCANNABINOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; POLYPHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; SATURATED FATTY ACID; TRANSCRIPTION FACTOR FOXO; UNSATURATED FATTY ACID;

AGING; ARTICLE; ATHEROSCLEROSIS; BIOGENESIS; CALORIC RESTRICTION; DIET RESTRICTION; DOWN REGULATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENERGY CONSERVATION; ENERGY EXPENDITURE; EXERCISE; HORMESIS; HUMAN; HYPERTENSION; IMMUNE SYSTEM; INSULIN RESISTANCE; LIFE EXPECTANCY; LIFESTYLE; METABOLIC SYNDROME X; MITOCHONDRION; NEGATIVE FEEDBACK; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION;

EID: 65549096847     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-6-16     Document Type: Article

References (305)

1. Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 2003 916 i 149 12768890
2. The metabolic syndrome: a global public health problem and a new definition. P Zimmet D Magliano Y Matsuzawa G Alberti J Shaw, J Atheroscler Thromb 2005 12 295 300 16394610
3. Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. K Fujita H Nishizawa T Funahashi I Shimomura M Shimabukuro, Circ J 2006 70 1437 1442 17062967 (Pubitemid 44672900)
4. Increased oxidative stress in obesity and its impact on metabolic syndrome. S Furukawa T Fujita M Shimabukuro M Iwaki Y Yamada Y Nakajima O Nakayama M Makishima M Matsuda I Shimomura, J Clin Invest 2004 114 1752 1761 15599400 (Pubitemid 40385531)
5. Impact of visceral fat on the metabolic syndrome and nonalcoholic fatty liver disease. SK Jeong YK Kim JW Park YJ Shin DS Kim, J Korean Med Sci 2008 23 789 795 18955783
6. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. PD van der KL Milner J Hui A Hodge MI Trenell JG Kench R London T Peduto DJ Chisholm J George, Hepatology 2008 48 449 457 18627003
7. Inflammation and metabolic disorders. GS Hotamisligil, Nature 2006 444 860 867 17167474 (Pubitemid 46024993)
8. Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity. R Pasquali V Vicennati A Gambineri U Pagotto, Int J Obes (Lond) 2008 32 1764 1779 18838976
9. Metabolic flexibility. L Storlien ND Oakes DE Kelley, Proc Nutr Soc 2004 63 363 368 15294056 (Pubitemid 38787491)
10. Sirtuins as potential targets for metabolic syndrome. L Guarente, Nature 2006 444 868 874 17167475 (Pubitemid 46024994)
11. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. CT Murphy SA McCarroll CI Bargmann A Fraser RS Kamath J Ahringer H Li C Kenyon, Nature 2003 424 277 283 12845331 (Pubitemid 36899363)
12. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. J Nakae WH Biggs III T Kitamura WK Cavenee CV Wright KC Arden D Accili, Nat Genet 2002 32 245 253 12219087
13. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity. AG Dulloo, Horm Res 2006 65 Suppl 3 90 97 16612120 (Pubitemid 44689439)
14. Insulin resistance is an evolutionarily conserved physiological mechanism at the cellular level for protection against increased oxidative stress. A Erol, Bioessays 2007 29 811 818 17621670 (Pubitemid 47204286)
15. Reactive species and early manifestation of insulin resistance in type 2 diabetes. LE Fridlyand LH Philipson, Diabetes Obes Metab 2006 8 136 145 16448517
16. The thrifty epigenotype: an acquired and heritable predisposition for obesity and diabetes? R Stoger, Bioessays 2008 30 156 166 18197594
17. Relationship between insulin sensitivity and in vivo mitochondrial function in skeletal muscle. B Sirikul BA Gower GR Hunter DE Larson-Meyer BR Newcomer, Am J Physiol Endocrinol Metab 2006 291 E724 E728 16705059 (Pubitemid 44484913)
18. Truncal fat in relation to total body fat: influences of age, sex, ethnicity and fatness. CH Wu S Heshka J Wang RN Pierson Jr SB Heymsfield B Laferrere Z Wang JB Albu X Pi-Sunyer D Gallagher, Int J Obes (Lond) 2007 31 1384 1391 17452992 (Pubitemid 47339929)
19. Cold climate genes and the prevalence of type 2 diabetes mellitus. LE Fridlyand LH Philipson, Med Hypotheses 2006 67 1034 1041 16797871 (Pubitemid 44348798)
20. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. AE Civitarese S Carling LK Heilbronn MH Hulver B Ukropcova WA Deutsch SR Smith E Ravussin, PLoS Med 2007 4 e76 17341128 (Pubitemid 46495316)
21. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. G Lopez-Lluch N Hunt B Jones M Zhu H Jamieson S Hilmer MV Cascajo J Allard DK Ingram P Navas CR de, Proc Natl Acad Sci USA 2006 103 1768 1773 16446459 (Pubitemid 43228768)
22. Skeletal muscle mitochondrial dysfunction & diabetes. R Sreekumar KS Nair, Indian J Med Res 2007 125 399 410 17496364 (Pubitemid 46805454)
23. The mitochondrial energy transduction system and the aging process. A Navarro A Boveris, Am J Physiol Cell Physiol 2007 292 C670 C686 17020935 (Pubitemid 46263466)
24. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? JV NEEL, Am J Hum Genet 1962 14 353 362 13937884
25. Banting lecture 1988. Role of insulin resistance in human disease. GM Reaven, Diabetes 1988 37 1595 1607 3056758
26. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. CN Hales DJ Barker, Diabetologia 1992 35 595 601 1644236
27. Whole body magnetic resonance imaging of healthy newborn infants demonstrates increased central adiposity in Asian Indians. N Modi EL Thomas SN Uthaya S Umranikar JD Bell C Yajnik, Pediatr Res 2009 19190541
28. Intrauterine factors, adiposity, and hyperinsulinaemia. AM Prentice, BMJ 2003 327 880 881 14563718 (Pubitemid 37289957)
29. Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. GK Bandyopadhyay JG Yu J Ofrecio JM Olefsky, Diabetes 2005 54 2351 2359 16046301 (Pubitemid 41134262)
30. Gene expression profiles in peripheral blood mononuclear cells reflect the pathophysiology of type 2 diabetes. T Takamura M Honda Y Sakai H Ando A Shimizu T Ota M Sakurai H Misu S Kurita N Matsuzawa-Nagata M Uchikata S Nakamura R Matoba M Tanino K Matsubara S Kaneko, Biochem Biophys Res Commun 2007 361 379 384 17651698 (Pubitemid 47187270)
31. Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes. GS Hotamisligil, Diabetes 2005 54 Suppl 2 S73 S78 16306344 (Pubitemid 43343334)
32. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. MC Wang D Bohmann H Jasper, Cell 2005 121 115 125 15820683 (Pubitemid 40501172)
33. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. YG Ni N Wang DJ Cao N Sachan DJ Morris RD Gerard O Kuro BA Rothermel JA Hill, Proc Natl Acad Sci USA 2007 104 20517 20522 18077353
34. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. SW Oh A Mukhopadhyay N Svrzikapa F Jiang RJ Davis HA Tissenbaum, Proc Natl Acad Sci USA 2005 102 4494 4499 15767565 (Pubitemid 40397140)
35. Dynamic FoxO transcription factors. H Huang DJ Tindall, J Cell Sci 2007 120 2479 2487 17646672 (Pubitemid 47323857)
36. A forkhead in the road to longevity: the molecular basis of lifespan becomes clearer. BJ Morris, J Hypertens 2005 23 1285 1309 15942449 (Pubitemid 40933947)
37. AMP-activated protein kinase plays a role in the control of food intake. U Andersson K Filipsson CR Abbott A Woods K Smith SR Bloom D Carling CJ Small, J Biol Chem 2004 279 12005 12008 14742438 (Pubitemid 38445761)
38. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. T Kitamura Y Feng YI Kitamura SC Chua Jr AW Xu GS Barsh L Rossetti D Accili, Nat Med 2006 12 534 540 16604086
39. FoxO transcription factors in the maintenance of cellular homeostasis during aging. DA Salih A Brunet, Curr Opin Cell Biol 2008 20 126 136 18394876
40. Peroxisome proliferator-activated receptor gamma coactivator 1 in caloric restriction and other models of longevity. JC Corton HM Brown-Borg, J Gerontol A Biol Sci Med Sci 2005 60 1494 1509 16424281 (Pubitemid 43146455)
41. Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors. JC Corton U Apte SP Anderson P Limaye L Yoon J Latendresse C Dunn JI Everitt KA Voss C Swanson C Kimbrough JS Wong SS Gill RA Chandraratna MK Kwak TW Kensler TM Stulnig KR Steffensen JA Gustafsson HM Mehendale, J Biol Chem 2004 279 46204 46212 15302862 (Pubitemid 39491615)
42. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. J St-Pierre S Drori M Uldry JM Silvaggi J Rhee S Jager C Handschin K Zheng J Lin W Yang DK Simon R Bachoo BM Spiegelman, Cell 2006 127 397 408 17055439 (Pubitemid 44572377)
43. The role of exercise and PGC1alpha in inflammation and chronic disease. C Handschin BM Spiegelman, Nature 2008 454 463 469 18650917
44. Autophagy genes and ageing. T Vellai, Cell Death Differ 2009 16 94 102 19079287
45. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. VT Samuel CS Choi TG Phillips AJ Romanelli JG Geisler S Bhanot R McKay B Monia JR Shutter RA Lindberg GI Shulman MM Veniant, Diabetes 2006 55 2042 2050 16804074 (Pubitemid 44509978)
46. The role of FoxO in the regulation of metabolism. DN Gross AP van den Heuvel MJ Birnbaum, Oncogene 2008 27 2320 2336 18391974
47. Forkhead transcription factor FoxO1 in adipose tissue regulates energy storage and expenditure. J Nakae Y Cao M Oki Y Orba H Sawa H Kiyonari K Iskandar K Suga M Lombes Y Hayashi, Diabetes 2008 57 563 576 18162510
48. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. T Kitamura J Nakae Y Kitamura Y Kido WH Biggs III CV Wright MF White KC Arden D Accili, J Clin Invest 2002 110 1839 1847 12488434 (Pubitemid 36076491)
49. The Brain-Gut-Islet connection. SC Woods SC Benoit DJ Clegg, Diabetes 2006 55 supplement 2 S114 S121
50. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. X Lin A Taguchi S Park JA Kushner F Li Y Li MF White, J Clin Invest 2004 114 908 916 15467829 (Pubitemid 39578718)
51. Cross-talk between the insulin and leptin signaling systems in rat hypothalamus. JB Carvalheira MA Torsoni M Ueno ME Amaral EP Araujo LA Velloso JA Gontijo MJ Saad, Obes Res 2005 13 48 57 15761162
52. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. PW Franks S Brage J Luan U Ekelund M Rahman IS Farooqi I Halsall S O'Rahilly NJ Wareham, Obes Res 2005 13 1476 1484 16129731
53. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. JD Erusalimsky S Moncada, Arterioscler Thromb Vasc Biol 2007 27 2524 2531 17885213 (Pubitemid 350158901)
54. Healthy aging: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: the essential roles of superoxide anion and hydrogen peroxide. AW Linnane M Kios L Vitetta, Biogerontology 2007 8 445 467 17415678 (Pubitemid 47365335)
55. ROS as a tumour suppressor? MR Ramsey NE Sharpless, Nat Cell Biol 2006 8 1213 1215 17077852 (Pubitemid 44660583)
56. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. MA Essers S Weijzen AM de Vries-Smits I Saarloos ND de Ruiter JL Bos BM Burgering, EMBO J 2004 23 4802 4812 15538382 (Pubitemid 40069710)
57. Resist or die: FOXO transcription factors determine the cellular response to chemotherapy. AR Gomes JJ Brosens EW Lam, Cell Cycle 2008 7 3133 3136 18927504
58. Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis. T Nakamura K Sakamoto, Mol Cell Endocrinol 2008 281 47 55 18035477 (Pubitemid 350296601)
59. The regulation of AMP-activated protein kinase by H(2)O(2). SL Choi SJ Kim KT Lee J Kim J Mu MJ Birnbaum KS Soo J Ha, Biochem Biophys Res Commun 2001 287 92 97 11549258
60. Role of reactive oxygen species in contraction-mediated glucose transport in mouse skeletal muscle. ME Sandstrom SJ Zhang J Bruton JP Silva MB Reid H Westerblad A Katz, J Physiol 2006 575 251 262 16777943 (Pubitemid 44178142)
61. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. P Dandona A Aljada A Chaudhuri P Mohanty R Garg, Circulation 2005 111 1448 1454 15781756 (Pubitemid 40396812)
62. O-GlcNAc regulates FoxO activation in response to glucose. MP Housley JT Rodgers ND Udeshi TJ Kelly J Shabanowitz DF Hunt P Puigserver GW Hart, J Biol Chem 2008 283 16283 16292 18420577
63. A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout. JA Hanover ME Forsythe PT Hennessey TM Brodigan DC Love G Ashwell M Krause, Proc Natl Acad Sci USA 2005 102 11266 11271 16051707 (Pubitemid 41153809)
64. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. RJ Copeland JW Bullen GW Hart, Am J Physiol Endocrinol Metab 2008 295 E17 E28 18445751
65. Long-term starvation and ageing induce AGE-1/PI 3-kinase-dependent translocation of DAF-16/FOXO to the cytoplasm. D Weinkove JR Halstead D Gems N Divecha, BMC Biol 2006 4 1 16457721
66. Is susceptibility to weight gain characterized by homeostatic or hedonic risk factors for overconsumption? JE Blundell G Finlayson, Physiol Behav 2004 82 21 25 15234585 (Pubitemid 38968503)
67. Variability of appetite control mechanisms in response to 9 weeks of progressive overfeeding in humans. SA Jebb M Siervo G Fruhbeck GR Goldberg PR Murgatroyd AM Prentice, Int J Obes (Lond) 2006 30 1160 1162 16477273 (Pubitemid 43980589)
68. Is the energy homeostasis system inherently biased toward weight gain? MW Schwartz SC Woods RJ Seeley GS Barsh DG Baskin RL Leibel, Diabetes 2003 52 232 238 12540591 (Pubitemid 36173173)
69. FOXO1 functions as a master switch that regulates gene expression necessary for tumor necrosis factor-induced fibroblast apoptosis. M Alikhani Z Alikhani DT Graves, J Biol Chem 2005 280 12096 12102 15632117 (Pubitemid 40491019)
70. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. MC Hu DF Lee W Xia LS Golfman F Ou-Yang JY Yang Y Zou S Bao N Hanada H Saso R Kobayashi MC Hung, Cell 2004 117 225 237 15084260 (Pubitemid 38496242)
71. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. CT De Souza EP Araujo S Bordin R Ashimine RL Zollner AC Boschero MJ Saad LA Velloso, Endocrinology 2005 146 4192 4199 16002529 (Pubitemid 41324012)
72. The role of leptin in leptin resistance and obesity. Y Zhang PJ Scarpace, Physiol Behav 2006 88 249 256 16782141 (Pubitemid 43913899)
73. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. ZB Andrews ZW Liu N Walllingford DM Erion E Borok JM Friedman MH Tschop M Shanabrough G Cline GI Shulman A Coppola XB Gao TL Horvath S Diano, Nature 2008 454 846 851 18668043
74. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. B Kola I Farkas M Christ-Crain G Wittmann F Lolli F Amin J Harvey-White Z Liposits G Kunos AB Grossman C Fekete M Korbonits, PLoS ONE 2008 3 e1797 18335063
75. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. JS Volek RD Feinman, Nutr Metab (Lond) 2005 2 31 16288655 (Pubitemid 43127497)
76. Biochemistry and molecular cell biology of diabetic complications. M Brownlee, Nature 2001 414 813 820 11742414 (Pubitemid 34000785)
77. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus. JA Maassen JA Romijn RJ Heine, Diabetologia 2007 50 2036 2041 17712547 (Pubitemid 47373858)
78. Obese humans as economically designed feed converters: symmorphosis and low oxidative capacity skeletal muscle. NJ Hudson SA Lehnert GS Harper, Med Hypotheses 2008 70 693 697 17664046
79. Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: "Mitohormesis" for health and vitality. PC Tapia, Med Hypotheses 2006 66 832 843 16242247 (Pubitemid 43181634)
80. Antagonistic pleiotropy and the stress theory of aging. PA Parsons, Biogerontology 2007 8 613 617 17610139 (Pubitemid 47365348)
81. Involvement of plasma membrane redox systems in hormone action. S Incerpi AM Fiore VP De JZ Pedersen, J Pharm Pharmacol 2007 59 1711 1720 18053334 (Pubitemid 350221815)
82. Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. A Matsuzawa H Ichijo, Biochim Biophys Acta 2008 1780 1325 1336 18206122
83. Tumor cell phenotype is sustained by selective MAPK oxidation in mitochondria. S Galli VG ntico Arciuch C Poderoso DP Converso Q Zhou JE Bal de Kier E Cadenas J Boczkowski MC Carreras JJ Poderoso, PLoS ONE 2008 3 e2379 18545666
84. Coordinated behavior of mitochondria in both space and time: a reactive oxygen species-activated wave of mitochondrial depolarization. NR Brady SP Elmore JJ van Beek K Krab PJ Courtoy L Hue HV Westerhoff, Biophys J 2004 87 2022 2034 15345578 (Pubitemid 39167056)
85. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. PS Brookes Y Yoon JL Robotham MW Anders SS Sheu, Am J Physiol Cell Physiol 2004 287 C817 C833 15355853 (Pubitemid 39238305)
86. A new activating role for CO in cardiac mitochondrial biogenesis. HB Suliman MS Carraway LG Tatro CA Piantadosi, J Cell Sci 2007 120 299 308 17179207 (Pubitemid 46243248)
87. A redox cycle within the cell cycle: ring in the old with the new. SG Menon PC Goswami, Oncogene 2007 26 1101 1109 16924237 (Pubitemid 46310447)
88. iNOS activity is critical for the clearance of Burkholderia mallei from infected RAW 264.7 murine macrophages. PJ Brett MN Burtnick H Su V Nair FC Gherardini, Cell Microbiol 2008 10 487 498 17970762
89. TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. A Valerio A Cardile V Cozzi R Bracale L Tedesco A Pisconti L Palomba O Cantoni E Clementi S Moncada MO Carruba E Nisoli, J Clin Invest 2006 116 2791 2798 16981010 (Pubitemid 44511642)
90. Coronary artery disease, nitric oxide and oxidative stress: the "Yin-Yang" effect-a Chinese concept for a worldwide pandemic. S Cook, Swiss Med Wkly 2006 136 103 113 16633954
91. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. E Nisoli C Tonello A Cardile V Cozzi R Bracale L Tedesco S Falcone A Valerio O Cantoni E Clementi S Moncada MO Carruba, Science 2005 310 314 317 16224023
92. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. M Hansen A Chandra LL Mitic B Onken M Driscoll C Kenyon, PLoS Genet 2008 4 e24 18282106
93. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. S Jager C Handschin J St-Pierre BM Spiegelman, Proc Natl Acad Sci USA 2007 104 12017 12022 17609368 (Pubitemid 47185622)
94. A fundamental system of cellular energy homeostasis regulated by PGC-1alpha. LM Rohas J St-Pierre M Uldry S Jager C Handschin BM Spiegelman, Proc Natl Acad Sci USA 2007 104 7933 7938 17470778 (Pubitemid 47185854)
95. mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. JT Cunningham JT Rodgers DH Arlow F Vazquez VK Mootha P Puigserver, Nature 2007 450 736 740 18046414 (Pubitemid 350207689)
96. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. S Nemoto MM Fergusson T Finkel, J Biol Chem 2005 280 16456 16460 15716268 (Pubitemid 40616776)
97. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. D Frescas L Valenti D Accili, J Biol Chem 2005 280 20589 20595 15788402 (Pubitemid 40776761)
98. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. KT Howitz KJ Bitterman HY Cohen DW Lamming S Lavu JG Wood RE Zipkin P Chung A Kisielewski LL Zhang B Scherer DA Sinclair, Nature 2003 425 191 196 12939617 (Pubitemid 37150899)
99. Isoflavones promote mitochondrial biogenesis. KA Rasbach RG Schnellmann, J Pharmacol Exp Ther 2008 325 536 543 18267976
100. Mitochondria-a nexus for aging, calorie restriction, and sirtuins? L Guarente, Cell 2008 132 171 176 18243090
101. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. TJ Schulz K Zarse A Voigt N Urban M Birringer M Ristow, Cell Metab 2007 6 280 293 17908557 (Pubitemid 47468090)
102. The role of AMP-activated protein kinase in mitochondrial biogenesis. RM Reznick GI Shulman, J Physiol 2006 574 33 39 16709637 (Pubitemid 43905794)
103. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle. GS Olsen BF Hansen, Am J Physiol Endocrinol Metab 2002 283 E965 E970 12376323 (Pubitemid 35216954)
104. Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats. EW Kraegen AK Saha E Preston D Wilks AJ Hoy GJ Cooney NB Ruderman, Am J Physiol Endocrinol Metab 2006 290 E471 E479 16234268 (Pubitemid 43671693)
105. Functions of AMP-activated protein kinase in adipose tissue. M Daval F Foufelle P Ferre, J Physiol 2006 574 55 62 16709632 (Pubitemid 43905796)
106. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. GR Steinberg, Cell Cycle 2007 6 888 894 17438370 (Pubitemid 46658739)
107. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. EL Greer PR Oskoui MR Banko JM Maniar MP Gygi SP Gygi A Brunet, J Biol Chem 2007 282 30107 30119 17711846 (Pubitemid 350035296)
108. Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues. M Fulco V Sartorelli, Cell Cycle 2008 7 3669 3679 19029811
109. Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons. TP Storozhevykh YE Senilova NA Persiyantseva VG Pinelis IA Pomytkin, BMC Neurosci 2007 8 84 17919343 (Pubitemid 350148947)
110. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. SM Schieke D Phillips JP McCoy Jr AM Aponte RF Shen RS Balaban T Finkel, J Biol Chem 2006 281 27643 27652 16847060 (Pubitemid 44401789)
111. Signaling mechanisms involved in the response to genotoxic stress and regulating lifespan. LJ Niedernhofer PD Robbins, Int J Biochem Cell Biol 2008 40 176 180 18023240 (Pubitemid 350137884)
112. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. SG Dann A Selvaraj G Thomas, Trends Mol Med 2007 13 252 259 17452018 (Pubitemid 46836871)
113. Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation. Z Arany BK Wagner Y Ma J Chinsomboon D Laznik BM Spiegelman, Proc Natl Acad Sci USA 2008 105 4721 4726 18347329
114. Glucocorticoid receptors and other nuclear transcription factors in mitochondria and possible functions. AM Psarra CE Sekeris, Biochim Biophys Acta 2008
115. Glucocorticoid hormone stimulates mitochondrial biogenesis specifically in skeletal muscle. K Weber P Bruck Z Mikes JH Kupper M Klingenspor RJ Wiesner, Endocrinology 2002 143 177 184 11751607 (Pubitemid 34056417)
116. Lipopolysaccharide induces oxidative cardiac mitochondrial damage and biogenesis. HB Suliman KE Welty-Wolf M Carraway L Tatro CA Piantadosi, Cardiovasc Res 2004 64 279 288 15485687 (Pubitemid 39361689)
117. The integration of lipid-sensing and anti-inflammatory effects: how the PPARs play a role in metabolic balance. AV Nunn J Bell P Barter, Nucl Recept 2007 5 1 17531095 (Pubitemid 47029155)
118. Motif module map reveals enforcement of aging by continual NF-kappaB activity. AS Adler S Sinha TL Kawahara JY Zhang E Segal HY Chang, Genes Dev 2007 21 3244 3257 18055696 (Pubitemid 350277752)
119. Constitutive activation of NF-kappa B in an animal model of aging. NF Spencer ME Poynter SY Im RA Daynes, Int Immunol 1997 9 1581 1588 9352364 (Pubitemid 27434691)
120. The evolution of aging: a new approach to an old problem of biology. JT Bowles, Med Hypotheses 1998 51 179 221 9792199
121. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. HA Hadi CS Carr SJ Al, Vasc Health Risk Manag 2005 1 183 198 17319104
122. Mechanisms of oxidative modification of low density lipoproteins under conditions of oxidative and carbonyl stress. VZ Lankin AK Tikhaze VI Kapel'ko GS Shepel'kova KB Shumaev OM Panasenko GG Konovalova YN Belenkov, Biochemistry (Mosc) 2007 72 1081 1090 18021066 (Pubitemid 350022591)
123. Anti-inflammatory agents and antioxidants as a possible "third great wave" in cardiovascular secondary prevention. DL Bhatt, Am J Cardiol 2008 101 4D 13D 18474273
124. Rapid increase in human life expectancy: will it soon be limited by the aging of elastin? L Robert AM Robert T Fulop, Biogerontology 2008 9 119 133 18175202
125. Depression: an important comorbidity with metabolic syndrome in a general population. JA Dunbar P Reddy N vis-Lameloise B Philpot T Laatikainen A Kilkkinen SJ Bunker JD Best E Vartiainen LS Kai ED Janus, Diabetes Care 2008 31 2368 2373 18835951
126. (Pre)diabetes, brain aging, and cognition. S Roriz-Filho TM Sa-Roriz I Rosset AL Camozzato AC Santos ML Chaves JC Moriguti M Roriz-Cruz, Biochim Biophys Acta 2008
127. Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. MD von S Safii SK Jassal J Svartberg E Barrett-Connor, Osteoporos Int 2007 18 1337 1344 17492393 (Pubitemid 47389466)
128. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. IM Wahba RH Mak, Clin J Am Soc Nephrol 2007 2 550 562 17699463
129. Symposium introduction: metabolic syndrome and the onset of cancer. JR Zhou GL Blackburn WA Walker, Am J Clin Nutr 2007 86 s817 s819 18265474
130. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. JM Fernandez-Real W Ricart, Diabetologia 1999 42 1367 1374 10550422 (Pubitemid 29500975)
131. Leptin regulates energetic tradeoffs between body fat and humoural immunity. GE Demas S Sakaria, Proc Biol Sci 2005 272 1845 1850 16096098 (Pubitemid 41414666)
132. Chronic activation of the innate immune system may underlie the metabolic syndrome. BB Duncan MI Schmidt, Sao Paulo Med J 2001 119 122 127 11391456
133. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. JC Pickup MB Mattock GD Chusney D Burt, Diabetologia 1997 40 1286 1292 9389420 (Pubitemid 27469668)
134. Visceral obesity and diabetes. P Bjorntorp R Rosmond, Drugs 1999 58 Suppl 1 13 18 10576519 (Pubitemid 129758576)
135. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. JL Evans ID Goldfine BA Maddux GM Grodsky, Endocr Rev 2002 23 599 622 12372842 (Pubitemid 35191625)
136. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. G Solinas C Vilcu JG Neels GK Bandyopadhyay JL Luo W Naugler S Grivennikov A Wynshaw-Boris M Scadeng JM Olefsky M Karin, Cell Metab 2007 6 386 397 17983584 (Pubitemid 350012000)
137. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. G Tuncman J Hirosumi G Solinas L Chang M Karin GS Hotamisligil, Proc Natl Acad Sci USA 2006 103 10741 10746 16818881 (Pubitemid 44078046)
138. A central role for JNK in obesity and insulin resistance. J Hirosumi G Tuncman L Chang CZ Gorgun KT Uysal K Maeda M Karin GS Hotamisligil, Nature 2002 420 333 336 12447443 (Pubitemid 35398190)
139. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. C Bubici S Papa K Dean G Franzoso, Oncogene 2006 25 6731 6748 17072325 (Pubitemid 44657849)
140. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. H Nakano A Nakajima S Sakon-Komazawa JH Piao X Xue K Okumura, Cell Death Differ 2006 13 730 737 16341124
141. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. S Cinti G Mitchell G Barbatelli I Murano E Ceresi E Faloia S Wang M Fortier AS Greenberg MS Obin, J Lipid Res 2005 46 2347 2355 16150820 (Pubitemid 41532523)
142. Dynamics of fat cell turnover in humans. KL Spalding E Arner PO Westermark S Bernard BA Buchholz O Bergmann L Blomqvist J Hoffstedt E Naslund T Britton H Concha M Hassan M Ryden J Frisen P Arner, Nature 2008 453 783 787 18454136
143. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. JY Kim WE van de M Laplante A Azzara ME Trujillo SM Hofmann T Schraw JL Durand H Li G Li LA Jelicks MF Mehler DY Hui Y Deshaies GI Shulman GJ Schwartz PE Scherer, J Clin Invest 2007 117 2621 2637 17717599 (Pubitemid 47494363)
144. Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways. P Dowell TC Otto S Adi MD Lane, J Biol Chem 2003 278 45485 45491 12966085 (Pubitemid 37432687)
145. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. P Delerive BK De S Besnard BW Vanden JM Peters FJ Gonzalez JC Fruchart A Tedgui G Haegeman B Staels, J Biol Chem 1999 274 32048 32054 10542237 (Pubitemid 129503797)
146. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes. A Planavila R Rodriguez-Calvo M Jove L Michalik W Wahli JC Laguna M Vazquez-Carrera, Cardiovasc Res 2005 65 832 841 15721863 (Pubitemid 40249728)
147. PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells. Y Rival N Beneteau T Taillandier M Pezet E Dupont-Passelaigue JF Patoiseau D Junquero FC Colpaert A Delhon, Eur J Pharmacol 2002 435 143 151 11821020 (Pubitemid 34131694)
148. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. DM Tham B Martin-McNulty YX Wang DW Wilson R Vergona ME Sullivan W Dole JC Rutledge, Physiol Genomics 2002 11 21 30 12361987
149. regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis. JE Kim J Chen, Diabetes 2004 53 2748 2756 15504954 (Pubitemid 39425899)
150. Inhibiting endogenous cortisol blunts the meal-entrained rise in serum leptin. B Laferrere C Abraham M Awad S Jean-Baptiste AB Hart P Garcia-Lorda P Kokkoris CD Russell, J Clin Endocrinol Metab 2006 91 2232 2238 16537679 (Pubitemid 43855011)
151. The neurobiology of human obesity. N Eikelis M Esler, Exp Physiol 2005 90 673 682 16105936 (Pubitemid 41406055)
152. The selfish brain: competition for energy resources. HL Fehm W Kern A Peters, Prog Brain Res 2006 153 129 140 16876572 (Pubitemid 44107413)
153. A laboratory exercise to illustrate increased salivary cortisol in response to three stressful conditions using competitive ELISA. MF Haussmann CM Vleck ES Farrar, Adv Physiol Educ 2007 31 110 115 17327591
154. Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch. R Malcher-Lopes A Franco JG Tasker, Eur J Pharmacol 2008 583 322 339 18295199
155. Dyslipidemia and inflammation: an evolutionary conserved mechanism. E Esteve W Ricart JM Fernandez-Real, Clin Nutr 2005 24 16 31 15681098
156. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. W Khovidhunkit MS Kim RA Memon JK Shigenaga AH Moser KR Feingold C Grunfeld, J Lipid Res 2004 45 1169 1196 15102878 (Pubitemid 38802622)
157. High density lipoprotein: guardian of the vascular system? C Packard A Nunn R Hobbs, Int J Clin Pract 2002 56 761 771 12510950 (Pubitemid 36104544)
158. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. BL Wajchenberg, Endocr Rev 2000 21 697 738 11133069 (Pubitemid 32113289)
159. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. M Navab GM Ananthramaiah ST Reddy BJ Van Lenten BJ Ansell GC Fonarow K Vahabzadeh S Hama G Hough N Kamranpour JA Berliner AJ Lusis AM Fogelman, J Lipid Res 2004 45 993 1007 15060092 (Pubitemid 38679495)
160. The role for endoplasmic reticulum stress in diabetes mellitus. DL Eizirik AK Cardozo M Cnop, Endocr Rev 2008 29 42 61 18048764
161. From endoplasmic-reticulum stress to the inflammatory response. K Zhang RJ Kaufman, Nature 2008 454 455 462 18650916
162. Visceral adipose tissue modulates mammalian longevity. R Muzumdar DB Allison DM Huffman X Ma G Atzmon FH Einstein S Fishman AD Poduval T McVei SW Keith N Barzilai, Aging Cell 2008 7 438 440 18363902
163. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. ES Freedland, Nutr Metab (Lond) 2004 1 12 15530168 (Pubitemid 40404843)
164. Alternate-day fasting and chronic disease prevention: a review of human and animal trials. KA Varady MK Hellerstein, Am J Clin Nutr 2007 86 7 13 17616757 (Pubitemid 47041587)
165. In vitro cellular adaptations of indicators of longevity in response to treatment with serum collected from humans on calorie restricted diets. JS Allard LK Heilbronn C Smith ND Hunt DK Ingram E Ravussin CR de, PLoS ONE 2008 3 e3211 18791640
166. Effects of modified alternate-day fasting regimens on adipocyte size, triglyceride metabolism, and plasma adiponectin levels in mice. KA Varady DJ Roohk YC Loe BK Evoy-Hein MK Hellerstein, J Lipid Res 2007 48 2212 2219 17607017 (Pubitemid 47529563)
167. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. CS Wang ST Wang WJ Yao TT Chang P Chou, Am J Epidemiol 2007 166 196 203 17496314 (Pubitemid 47227286)
168. Plant-based foods and prevention of cardiovascular disease: an overview. FB Hu, Am J Clin Nutr 2003 78 544S 551S 12936948 (Pubitemid 40012548)
169. Serum fatty acids and the risk of coronary heart disease. JA Simon ML Hodgkins WS Browner JM Neuhaus JT Bernert Jr SB Hulley, Am J Epidemiol 1995 142 469 476 7677125
170. Consumption of fish and fish oils and decreased risk of stroke. PJ Skerrett CH Hennekens, Prev Cardiol 2003 6 38 41 12624561 (Pubitemid 36278876)
171. Humans, lipids and evolution. SB Eaton, Lipids 1992 27 814 820 1435101
172. Dietary intake of long-chain polyunsaturated fatty acids during the paleolithic. SB Eaton SB Eaton III AJ Sinclair L Cordain NJ Mann, World Rev Nutr Diet 1998 83 12 23 9648501 (Pubitemid 128081428)
173. The public health significance of fat-modified ruminant foods. PF Heywood, Am J Clin Nutr 1977 30 1726 1733 910748 (Pubitemid 8205365)
174. Dietary survey of the FINMONICA project in 1982. P Pietinen U Uusitalo E Vartiainen J Tuomilehto, Acta Med Scand Suppl 1988 728 169 177 3202027 (Pubitemid 19047667)
175. Vitamin E in humans: an explanation of clinical trial failure. I Robinson DG de Serna A Gutierrez DS Schade, Endocr Pract 2006 12 576 582 17002935 (Pubitemid 46456048)
176. The kinetics of the autoxidation of polyunsaturated fatty acids. JP Cosgrove DF Church WA Pryor, Lipids 1987 22 299 304 3600206
177. Mitochondrial phospholipids of rat skeletal muscle are less polyunsaturated than whole tissue phospholipids: implications for protection against oxidative stress. S Tsalouhidou C Argyrou G Theofilidis D Karaoglanidis E Orfanidou MG Nikolaidis A Petridou V Mougios, J Anim Sci 2006 84 2818 2825 16971584 (Pubitemid 44505444)
178. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. H Esterbauer RJ Schaur H Zollner, Free Radic Biol Med 1991 11 81 128 1937131 (Pubitemid 121003917)
179. Induction of mitochondrial nitrative damage and cardiac dysfunction by chronic provision of dietary omega-6 polyunsaturated fatty acids. S Ghosh G Kewalramani G Yuen T Pulinilkunnil D An SM Innis MF Allard RB Wambolt D Qi A Abrahani B Rodrigues, Free Radic Biol Med 2006 41 1413 1424 17023268 (Pubitemid 44466725)
180. Polyunsaturated fatty acids mobilize intracellular Ca2+ in NT2 human teratocarcinoma cells by causing release of Ca2+ from mitochondria. BX Zhang X Ma W Zhang CK Yeh A Lin J Luo EA Sprague RH Swerdlow MS Katz, Am J Physiol Cell Physiol 2006 290 C1321 C1333 16601147
181. Effect of lifelong coenzyme Q10 supplementation on age-related oxidative stress and mitochondrial function in liver and skeletal muscle of rats fed on a polyunsaturated fatty acid (PUFA)-rich diet. JJ Ochoa JL Quiles M Lopez-Frias JR Huertas J Mataix, J Gerontol A Biol Sci Med Sci 2007 62 1211 1218 18000140 (Pubitemid 350287609)
182. Mechanisms mediating the effects of prepubertal (n-3) polyunsaturated fatty acid diet on breast cancer risk in rats. L Hilakivi-Clarke SE Olivo A Shajahan G Khan Y Zhu A Zwart E Cho R Clarke, J Nutr 2005 135 2946S 2952S 16317153 (Pubitemid 43156571)
183. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. HE Xu MH Lambert VG Montana DJ Parks SG Blanchard PJ Brown DD Sternbach JM Lehmann GB Wisely TM Willson SA Kliewer MV Milburn, Mol Cell 1999 3 397 403 10198642 (Pubitemid 29290680)
184. Dietary fatty acids Up-regulate the expression of UCP2 in 3T3-L1 preadipocytes. JM Reilly MP Thompson, Biochem Biophys Res Commun 2000 277 541 545 11061990
185. Polyunsaturated fatty acids stimulate hepatic UCP-2 expression via a PPARalpha-mediated pathway. MB Armstrong HC Towle, Am J Physiol Endocrinol Metab 2001 281 E1197 E1204 11701434 (Pubitemid 33775069)
186. Mitochondrial uncoupling proteins-what is their physiological role? KS Echtay, Free Radic Biol Med 2007 43 1351 1371 17936181 (Pubitemid 47532367)
187. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. C Weigert K Brodbeck H Staiger C Kausch F Machicao HU Haring ED Schleicher, J Biol Chem 2004 279 23942 23952 15028733 (Pubitemid 38725252)
188. UCP-mediated energy depletion in skeletal muscle increases glucose transport despite lipid accumulation and mitochondrial dysfunction. DH Han LA Nolte JS Ju T Coleman JO Holloszy CF Semenkovich, Am J Physiol Endocrinol Metab 2004 286 E347 E353 14613927 (Pubitemid 38292683)
189. CD36 in myocytes channels fatty acids to a lipase-accessible triglyceride pool that is related to cell lipid and insulin responsiveness. CC Bastie T Hajri VA Drover PA Grimaldi NA Abumrad, Diabetes 2004 53 2209 2216 15331529 (Pubitemid 39145573)
190. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. P Schrauwen MK Hesselink, Diabetes 2004 53 1412 1417 15161742
191. UCP2 and UCP3 in muscle controlling body metabolism. P Schrauwen M Hesselink, J Exp Biol 2002 205 2275 2285 12110661
192. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. VK Mootha CM Lindgren KF Eriksson A Subramanian S Sihag J Lehar P Puigserver E Carlsson M Ridderstrale E Laurila N Houstis MJ Daly N Patterson JP Mesirov TR Golub P Tamayo B Spiegelman ES Lander JN Hirschhorn D Altshuler LC Groop, Nat Genet 2003 34 267 273 12808457 (Pubitemid 36792858)
193. Starvation-sensitive UCP 3 protein expression in thymus and spleen mitochondria. AM Carroll RK Porter, Biochim Biophys Acta 2004 1700 145 150 15262223
194. The ketogenic diet increases mitochondrial uncoupling protein levels and activity. PG Sullivan NA Rippy K Dorenbos RC Concepcion AK Agarwal JM Rho, Ann Neurol 2004 55 576 580 15048898 (Pubitemid 38391976)
195. Expression of lung uncoupling protein-2 mRNA is modulated developmentally and by caloric intake. H Xiao D Massaro GD Massaro LB Clerch, Exp Biol Med (Maywood) 2004 229 479 485 15169966 (Pubitemid 38736316)
196. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. DT Stein BE Stevenson MW Chester M Basit MB Daniels SD Turley JD McGarry, J Clin Invest 1997 100 398 403 9218517 (Pubitemid 27349087)
197. PPAR-gamma overexpression selectively suppresses insulin secretory capacity in isolated pancreatic islets through induction of UCP-2 protein. E Ito S Ozawa K Takahashi T Tanaka H Katsuta S Yamaguchi M Maruyama M Takizawa H Katahira K Yoshimoto S Nagamatsu H Ishida, Biochem Biophys Res Commun 2004 324 810 814 15474499 (Pubitemid 39345587)
198. Pancreatic islet adaptation to fasting is dependent on peroxisome proliferator-activated receptor alpha transcriptional up-regulation of fatty acid oxidation. S Gremlich C Nolan R Roduit R Burcelin ML Peyot V ghingaro-Augusto B Desvergne L Michalik M Prentki W Wahli, Endocrinology 2005 146 375 382 15459119 (Pubitemid 40051761)
199. PPARdelta regulates glucose metabolism and insulin sensitivity. CH Lee P Olson A Hevener I Mehl LW Chong JM Olefsky FJ Gonzalez J Ham H Kang JM Peters RM Evans, Proc Natl Acad Sci USA 2006 103 3444 3449 16492734 (Pubitemid 43346488)
200. Improvement of Insulin Sensitivity after Peroxisome Proliferator- Activated Receptor-{alpha} Agonist Treatment Is Accompanied by Paradoxical Increase of Circulating Resistin Levels. MM Haluzik Z Lacinova M Dolinkova D Haluzikova D Housa A Horinek Z Vernerova T Kumstyrova M Haluzik, Endocrinology 2006 147 4517 4524 16740970 (Pubitemid 44268403)
201. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. JM Ye PJ Doyle MA Iglesias DG Watson GJ Cooney EW Kraegen, Diabetes 2001 50 411 417 11272155 (Pubitemid 32127300)
202. Glucocorticoids alter the lipid and protein composition of membrane rafts of a murine T cell hybridoma. LF Van X Liang F Andris J Urbain M Vandenbranden JM Ruysschaert MD Resh TM Stulnig O Leo, J Immunol 2003 170 2932 2939 12626544 (Pubitemid 36302164)
203. The modulation of inflammatory gene expression by lipids: mediation through Toll-like receptors. JY Lee DH Hwang, Mol Cells 2006 21 174 185 16682810
204. TLR4 links innate immunity and fatty acid-induced insulin resistance. H Shi MV Kokoeva K Inouye I Tzameli H Yin JS Flier, J Clin Invest 2006 116 3015 3025 17053832 (Pubitemid 44684486)
205. Lipid mediators in membrane rafts are important determinants of human health and disease. DW Ma, Appl Physiol Nutr Metab 2007 32 341 350 17510668
206. Signal transduction of stress via ceramide. S Mathias LA Pena RN Kolesnick, Biochem J 1998 335 Pt 3 465 480 9794783
207. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. C Schmitz-Peiffer DL Craig TJ Biden, J Biol Chem 1999 274 24202 24210 10446195 (Pubitemid 129528468)
208. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. J Lin R Yang PT Tarr PH Wu C Handschin S Li W Yang L Pei M Uldry P Tontonoz CB Newgard BM Spiegelman, Cell 2005 120 261 273 15680331 (Pubitemid 40174768)
209. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. A Hirasawa K Tsumaya T Awaji S Katsuma T Adachi M Yamada Y Sugimoto S Miyazaki G Tsujimoto, Nat Med 2005 11 90 94 15619630 (Pubitemid 40215843)
210. Dietary fats, fatty acids and insulin resistance: short review of a multifaceted connection. M Haag NG Dippenaar, Med Sci Monit 2005 11 RA359 RA367 16319806 (Pubitemid 43138433)
211. Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression. H Wang LH Storlien XF Huang, Am J Physiol Endocrinol Metab 2002 282 E1352 E1359 12006366 (Pubitemid 34654705)
212. Quality of dietary fatty acids, insulin sensitivity and type 2 diabetes. AA Rivellese S Lilli, Biomed Pharmacother 2003 57 84 87 12842493
213. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. VL Marcheselli S Hong WJ Lukiw XH Tian K Gronert A Musto M Hardy JM Gimenez N Chiang CN Serhan NG Bazan, J Biol Chem 2003 278 43807 43817 12923200 (Pubitemid 37346009)
214. Endocannabinoids and neuroprotection. R Mechoulam M Spatz E Shohami, Sci STKE 2002 2002 RE5 11972360
215. Rapidly increased neuronal mitochondrial biogenesis after hypoxic-ischemic brain injury. W Yin AP Signore M Iwai G Cao Y Gao J Chen, Stroke 2008 39 3057 3063 18723421
216. Critical role of the endocannabinoid system in the regulation of food intake and energy metabolism, with phylogenetic, developmental, and pathophysiological implications. MP Viveros FR de Fonseca FJ Bermudez-Silva JM McPartland, Endocr Metab Immune Disord Drug Targets 2008 8 220 230 18782018
217. Endocannabinoid control of food intake and energy balance. MV Di I Matias, Nat Neurosci 2005 8 585 589 15856067
218. Rimonabant in rats with a metabolic syndrome: good news after the depression. MV Di A Szallasi, Br J Pharmacol 2008 154 915 917 18454166
219. Effects of rimonabant (SR141716) on fasting-induced hypothalamic- pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats. C Doyon RG Denis ED Baraboi P Samson J Lalonde Y Deshaies D Richard, Diabetes 2006 55 3403 3410 17130486
220. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. MA Steiner G Marsicano EJ Nestler F Holsboer B Lutz CT Wotjak, Psychoneuroendocrinology 2008 33 54 67 17976922
221. The CB1 endocannabinoid system modulates adipocyte insulin sensitivity. R Motaghedi TE McGraw, Obesity (Silver Spring) 2008 16 1727 1734 18551116
222. Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. K Eckardt H Sell A Taube M Koenen B Platzbecker A Cramer A Horrighs M Lehtonen N Tennagels J Eckel, Diabetologia 2009 52 664 674 19089403
223. The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance. O Jbilo C Ravinet-Trillou M Arnone I Buisson E Bribes A Peleraux G Penarier P Soubrie FG Le S Galiegue P Casellas, FASEB J 2005 19 1567 1569 16009704
224. Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. L Tedesco A Valerio C Cervino A Cardile C Pagano R Vettor R Pasquali MO Carruba G Marsicano B Lutz U Pagotto E Nisoli, Diabetes 2008 57 2028 2036 18477809
225. Rimonabant for overweight or obesity. C Curioni C Andre, Cochrane Database Syst Rev 2006 CD006162 17054276
226. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. A Zimmer AM Zimmer AG Hohmann M Herkenham TI Bonner, Proc Natl Acad Sci USA 1999 96 5780 5785 10318961
227. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. B Kola E Hubina SA Tucci TC Kirkham EA Garcia SE Mitchell LM Williams SA Hawley DG Hardie AB Grossman M Korbonits, J Biol Chem 2005 280 25196 25201 15899896
228. Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors. SE O'Sullivan, Br J Pharmacol 2007 152 576 582 17704824
229. Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. X Du T Matsumura D Edelstein L Rossetti Z Zsengeller C Szabo M Brownlee, J Clin Invest 2003 112 1049 1057 14523042
230. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Y Lavrovsky B Chatterjee RA Clark AK Roy, Exp Gerontol 2000 35 521 532 10978675
231. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. CH Yeh L Sturgis J Haidacher XN Zhang SJ Sherwood RJ Bjercke O Juhasz MT Crow RG Tilton L Denner, Diabetes 2001 50 1495 1504 11375353
232. Hyperglycemia-induced production of acute phase reactants in adipose tissue. Y Lin MW Rajala JP Berger DE Moller N Barzilai PE Scherer, J Biol Chem 2001 276 42077 42083 11546817
233. Insulin as an anti-inflammatory and antiatherosclerotic hormone. P Dandona A Aljada S Dhindsa R Garg, Clin Cornerstone 2003 Suppl 4 S13 S20 14986904
234. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. A Accurso RK Bernstein A Dahlqvist B Draznin RD Feinman EJ Fine A Gleed DB Jacobs G Larson RH Lustig AH Manninen SI McFarlane K Morrison JV Nielsen U Ravnskov KS Roth R Silvestre JR Sowers R Sundberg JS Volek EC Westman RJ Wood J Wortman MC Vernon, Nutr Metab (Lond) 2008 5 9 18397522
235. Regulation of gene transcription by botanicals: novel regulatory mechanisms. NF Shay WJ Banz, Annu Rev Nutr 2005 25 297 315 16011469
236. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. YL Lin JK Lin, Mol Pharmacol 1997 52 465 472 9281609
237. Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin. S Anton L Melville G Rena, Cell Signal 2007 19 378 383 16950602
238. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. JG Wood B Rogina S Lavu K Howitz SL Helfand M Tatar D Sinclair, Nature 2004 430 686 689 15254550
239. Remodeling of white adipose tissue after retinoic acid administration in mice. J Mercader J Ribot I Murano F Felipe S Cinti ML Bonet A Palou, Endocrinology 2006 147 5325 5332 16840543
240. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha. AW Zomer BB van Der GA Jansen RJ Wanders BT Poll-The PT van Der Saag, J Lipid Res 2000 41 1801 1807 11060349
241. Retinoid × receptors: X-ploring their (patho)physiological functions. A Szanto V Narkar Q Shen IP Uray PJ Davies L Nagy, Cell Death Differ 2004 11 Suppl 2 S126 S143 15608692
242. Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. LM Austenaa H Carlsen A Ertesvag G Alexander HK Blomhoff R Blomhoff, FASEB J 2004 18 1255 1257 15180954
243. Molecular targets of dietary polyphenols with anti-inflammatory properties. JH Yoon SJ Baek, Yonsei Med J 2005 46 585 596 16259055
244. Higher plant antioxidants and redox signaling under environmental stresses. HB Shao LY Chu MA Shao CA Jaleel HM Mi, C R Biol 2008 331 433 441 18510996
245. Cell division in the unicellular microalga Dunaliella viridis depends on phosphorylation of extracellular signal-regulated kinases (ERKs). C Jimenez BR Cossio CJ Rivard T Berl JM Capasso, J Exp Bot 2007 58 1001 1011 17220513
246. Red wine polyphenols inhibit the growth of colon carcinoma cells and modulate the activation pattern of mitogen-activated protein kinases. K Briviba L Pan G Rechkemmer, J Nutr 2002 132 2814 2818 12221251
247. Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. MH Oak JE Bedoui SV Madeira K Chalupsky VB Schini-Kerth, Br J Pharmacol 2006 149 283 290 16921400
248. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. M Zang S Xu KA Maitland-Toolan A Zuccollo X Hou B Jiang M Wierzbicki TJ Verbeuren RA Cohen, Diabetes 2006 55 2180 2191 16873680
249. Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. J Zheng VD Ramirez, Br J Pharmacol 2000 130 1115 1123 10882397
250. Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. A Athanasiou AB Clarke AE Turner NM Kumaran S Vakilpour PA Smith D Bagiokou TD Bradshaw AD Westwell L Fang DN Lobo CS Constantinescu V Calabrese A Loesch SP Alexander RH Clothier DA Kendall TE Bates, Biochem Biophys Res Commun 2007 364 131 137 17931597
251. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. CM Klinge KA Blankenship KE Risinger S Bhatnagar EL Noisin WK Sumanasekera L Zhao DM Brey RS Keynton, J Biol Chem 2005 280 7460 7468 15615701
252. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. T Wallerath G Deckert T Ternes H Anderson H Li K Witte U Forstermann, Circulation 2002 106 1652 1658 12270858
253. Mitochondrial effects of estrogen are mediated by ER{alpha} in brain endothelial cells. A Razmara L Sunday C Stirone X Wang D Krause S Duckles V Procaccio, J Pharmacol Exp Ther 2008 18354059
254. Resveratrol protects against 4-hydroxynonenal-induced apoptosis by blocking JNK and c-JUN/AP-1 signaling. O Kutuk G Poli H Basaga, Toxicol Sci 2006 90 120 132 16322078
255. Resveratrol inhibits insulin responses in a SirT1-independent pathway. J Zhang, Biochem J 2006 397 519 527 16626303
256. Resveratrol improves health and survival of mice on a high-calorie diet. JA Baur KJ Pearson NL Price HA Jamieson C Lerin A Kalra VV Prabhu JS Allard G Lopez-Lluch K Lewis PJ Pistell S Poosala KG Becker O Boss D Gwinn M Wang S Ramaswamy KW Fishbein RG Spencer EG Lakatta CD Le RJ Shaw P Navas P Puigserver DK Ingram CR de DA Sinclair, Nature 2006 444 337 342 17086191
257. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. DR Valenzano E Terzibasi T Genade A Cattaneo L Domenici A Cellerino, Curr Biol 2006 16 296 300 16461283
258. Small molecules that regulate lifespan: evidence for xenohormesis. DW Lamming JG Wood DA Sinclair, Mol Microbiol 2004 53 1003 1009 15306006
259. AMPK and PPARdelta agonists are exercise mimetics. VA Narkar M Downes RT Yu E Embler YX Wang E Banayo MM Mihaylova MC Nelson Y Zou H Juguilon H Kang RJ Shaw RM Evans, Cell 2008 134 405 415 18674809
260. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. M Lagouge C Argmann Z Gerhart-Hines H Meziane C Lerin F Daussin N Messadeq J Milne P Lambert P Elliott B Geny M Laakso P Puigserver J Auwerx, Cell 2006 127 1109 1122 17112576
261. Metformin and body weight. A Golay, Int J Obes (Lond) 2008 32 61 72 17653063
262. Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species. MH Zou SS Kirkpatrick BJ Davis JS Nelson WG Wiles U Schlattner D Neumann M Brownlee MB Freeman MH Goldman, J Biol Chem 2004 279 43940 43951 15265871
263. Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. M Suwa T Egashira H Nakano H Sasaki S Kumagai, J Appl Physiol 2006 101 1685 1692 16902066
264. Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome. U Singh S Devaraj I Jialal D Siegel, Am J Cardiol 2008 102 321 325 18638594
265. Do statins reduce blood pressure?: a meta-analysis of randomized, controlled trials. P Strazzullo SM Kerry A Barbato M Versiero L D'Elia FP Cappuccio, Hypertension 2007 49 792 798 17309949
266. Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome. F Guclu B Ozmen Z Hekimsoy C Kirmaz, Biomed Pharmacother 2004 58 614 618 15589072
267. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. J Sasaki Y Ikeda T Kuribayashi K Kajiwara S Biro K Yamamoto M Ageta S Kobori T Saikawa T Otonari S Kono, Clin Ther 2008 30 1089 1101 18640465
268. The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials. CI Coleman K Reinhart J Kluger CM White, Curr Med Res Opin 2008 24 1359 1362 18384710
269. Protective effects of coenzyme q(10) on decreased oxidative stress resistance induced by simvastatin. A Kettawan T Takahashi R Kongkachuichai S Charoenkiatkul T Kishi T Okamoto, J Clin Biochem Nutr 2007 40 194 202 18398496
270. Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration. S Nadanaciva JA Dykens A Bernal RA Capaldi Y Will, Toxicol Appl Pharmacol 2007 223 277 287 17658574
271. Statins activate AMP-activated protein kinase in vitro and in vivo. W Sun TS Lee M Zhu C Gu Y Wang Y Zhu JY Shyy, Circulation 2006 114 2655 2662 17116771
272. Pharmacological preconditioning with simvastatin protects liver from ischemia-reperfusion injury by heme oxygenase-1 induction. IR Lai KJ Chang HW Tsai CF Chen, Transplantation 2008 85 732 738 18337668
273. Pravastatin reduces myocardial infarct size via increasing protein kinase C-dependent nitric oxide, decreasing oxyradicals and opening the mitochondrial adenosine triphosphate-sensitive potassium channels in rabbits. N Bao S Minatoguchi H Kobayashi S Yasuda I Kawamura M Iwasa T Yamaki S Sumi Y Misao M Arai K Nishigaki G Takemura T Fujiwara H Fujiwara, Circ J 2007 71 1622 1628 17895562
274. Simvastatin restores ischemic preconditioning in the presence of hyperglycemia through a nitric oxide-mediated mechanism. W Gu F Kehl JG Krolikowski PS Pagel DC Warltier JR Kersten, Anesthesiology 2008 108 634 642 18362595
275. Beyond HDL-cholesterol increase: phospholipid enrichment and shift from HDL3 to HDL2 in alcohol consumers. C Schafer A Parlesak J Eckoldt C Bode JC Bode W Marz K Winkler, J Lipid Res 2007 48 1550 1558 17431276
276. Alcohol-induced oxidative stress. SK Das DM Vasudevan, Life Sci 2007 81 177 187 17570440
277. Insulin resistance in experimental alcohol-induced liver disease. SM de la Monte JE Yeon M Tong L Longato R Chaudhry MY Pang K Duan JR Wands, J Gastroenterol Hepatol 2008 23 e477 e486 18505416
278. Alcohol consumption and insulin resistance in young adults. DE Flanagan VM Moore IF Godsland RA Cockington JS Robinson DI Phillips, Eur J Clin Invest 2000 30 297 301 10759877
279. Alcohol consumption, the metabolic syndrome and insulin resistance in 58-year-old clinically healthy men (AIR study). D Goude B Fagerberg J Hulthe, Clin Sci (Lond) 2002 102 345 352 11869176
280. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. RA Bell EJ Mayer-Davis MA Martin RB D'Agostino Jr SM Haffner, Diabetes Care 2000 23 1630 1636 11092284
281. Alcohol intake and insulin resistance. A cross-sectional study. R Villegas A Salim D O'Halloran IJ Perry, Nutr Metab Cardiovasc Dis 2004 14 233 240 15673056
282. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. D Porte Jr DG Baskin MW Schwartz, Diabetes 2005 54 1264 1276 15855309
283. Insulin signaling effects on memory and mood. LP Reagan, Curr Opin Pharmacol 2007 7 633 637 18023616
284. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. R Mastrocola F Restivo I Vercellinatto O Danni E Brignardello M Aragno G Boccuzzi, J Endocrinol 2005 187 37 44 16214939
285. Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier. A Urayama WA Banks, Endocrinology 2008 149 3592 3597 18403490
286. Influence of blood glucose on the expression of glucose trans-porter proteins 1 and 3 in the brain of diabetic rats. WK Hou YX Xian L Zhang H Lai XG Hou YX Xu T Yu FY Xu J Song CL Fu WW Zhang L Chen, Chin Med J (Engl) 2007 120 1704 1709 17935675
287. The PI3-K/Akt pathway: roles related to alterations in vasomotor responses in diabetic models. T Kobayashi T Matsumoto K Kamata, J Smooth Muscle Res 2005 41 283 302 16557003
288. Insulin-like signaling, nutrient homeostasis, and life span. A Taguchi MF White, Annu Rev Physiol 2008 70 191 212 17988211
289. Appetite for reproduction: dietary restriction, aging and the mammalian gonad. RL Nalam SD Pletcher MM Matzuk, J Biol 2008 7 23 18828876
290. Marine microbiology: origins of death. N Lane, Nature 2008 453 583 585 18509414
291. Why yeast cells can undergo apoptosis: death in times of peace, love, and war. S Buttner T Eisenberg E Herker D Carmona-Gutierrez G Kroemer F Madeo, J Cell Biol 2006 175 521 525 17101700
292. Phenoptosis: programmed death of an organism. VP Skulachev, Biochemistry (Mosc) 1999 64 1418 1426 10648966
293. A complete classification of Darwinian extinction in ecological interactions. C Webb, Am Nat 2003 161 181 205 12675367
294. Evolutionary suicide. K Parvinen, Acta Biotheor 2005 53 241 264 16329010
295. High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. F al-Mahroos PM McKeigue, Diabetes Care 1998 21 936 942 9614611
296. Overweight and obesity in the Arabian Peninsula: an overview. F al-Mahroos K Al-Roomi, J R Soc Health 1999 119 251 253
297. Weight, height, body mass index and prevalence of obesity among the adult population in Bahrain. AO Musaiger MA Al-Mannai, Ann Hum Biol 2001 28 346 350 11393341
298. Effect of BMI on lifetime risk for diabetes in the U.S. KM Narayan JP Boyle TJ Thompson EW Gregg DF Williamson, Diabetes Care 2007 30 1562 1566
299. Relation of diabetes to mild cognitive impairment. JA Luchsinger C Reitz B Patel MX Tang JJ Manly R Mayeux, Arch Neurol 2007 64 570 575 17420320
300. Hyperinsulinemia and cognitive decline in a middle-aged cohort. SE Young AG Mainous III M Carnemolla, Diabetes Care 2006 29 2688 2693 17130206
301. Obesity and sexual dysfunction, male and female. K Esposito F Giugliano M Ciotola SM De M D'Armiento D Giugliano, Int J Impot Res 2008 20 358 365 18401349
302. Correlated responses to selection for stress resistance and longevity in a laboratory population of Drosophila melanogaster. OA Bubliy V Loeschcke, J Evol Biol 2005 18 789 803 16033550
303. Aging, anti-aging, and hormesis. SI Rattan, Mech Ageing Dev 2004 125 285 289 15063104
304. Total mortality after changes in leisure time physical activity in 50 year old men: 35 year follow-up of population based cohort. L Byberg H Melhus R Gedeborg J Sundstrom A Ahlbom B Zethelius LG Berglund A Wolk K Michaelsson, BMJ 2009 338 b688 19264819
305. Sedentary behaviour, physical activity and a continuous metabolic syndrome risk score in adults. K Wijndaele N Duvigneaud L Matton W Duquet C Delecluse M Thomis G Beunen J Lefevre RM Philippaerts, Eur J Clin Nutr 2009 63 421 429 17971826